Laurent DECORYJan 4, 20211 minCOVID-19 to reshape R&D investments toward infectious diseasesInfectious diseases have been largely forgotten by Pharma R&D and investors, as chronic diseases, cancer and rare diseases gave better...
Laurent DECORYDec 13, 20201 minPost Brexit, will UK MedTech take back control or align with key markets ?While Brexit goal is officially to "take back control", UK MedTech may have to choose between aligning regulatory process with EU or US....
Laurent DECORYDec 13, 20201 minGermany bets on its Biotechs and mRNA COVID-19 vaccinesAfter granting €252M to CureVac, the German government has awarded €375M to BioNTech. BioNtech announcement: https://lnkd.in/dKinEe4...
Laurent DECORYDec 12, 20201 minGENFIT moves focus to promising NASH diagnosticIn a promising but risky NASH market, study shows GENFIT NIS4 easy test allows to identify patients who require treatment, without need...